PharmaBoardroom

Interview: Paul Glover, Associate Deputy Minister, Health Canada

A perspective from Canada’s national health body on the future of medicine in the 21st century, from the shift to personalized medicine to…

Interview: Jon Fairest, President & CEO, Sanofi Canada

The President & CEO of Sanofi Canada talks candidly about the pros and cons of the current administrative setup of the Canadian healthcare…

Interview: Johnsee Lee, Chairman, Development Center for…

A leading figure in the Taiwanese pharmaceutical sector, Lee divulges the practicalities behind ECFA, the free trade agreement that was signed between…

Interview: Ed Dybka, General Manager, Almirall Canada

Having only arrived on the market last year, the GM of Almirall in Canada explains the company's regulatory struggles, the utilization of Almirall’s…

Colombia: Confidence in uncertainty

Under the administration of President Juan Manuel Santos, Colombia is focusing on bolstering the commercial sector. While this is good news for the…

Interview: Hendra Gunawan, Managing Director, PT Tunggal Idaman…

A perspective on Indonesia’s booming market for contraceptive products from Hendra Gunawan, managing director of PT Tunggal Idaman Abdi, one of…

Interview: Andrew Casey, CEO, BIOTECanada

BIOTECanada is the national trade association for Canada’s biotech industry. Andrew Casey, the group’s CEO, discusses the impact of IP regulation…

Interview: Tom Rönnlund, General Manager Nordic & Baltic…

Tom Rönnlund discusses the current state of the pharmaceutical industry in the Nordics in this time of austerity, and offers opinions on reference…

The 3 T’s: Positioning Ireland for FDI

What makes Ireland attractive for FDI? As the former general manager of Genzyme‰Ûªs Waterford site, Pat O‰ÛªSullivan explains that a…

Ireland: up the ladder

Lilly set up in Ireland three decades ago by purchasing a farm. In its early days, the operation produced intermediaries for small-molecule drugs.…

Ireland: Cut costs or add value?

It is widely acknowledged that pharmaceutical manufacturing operations have entered into a period of significant cost reduction. Service providers…

From foreign investment, Irish companies

FDI into Ireland has created a feedstock for the indigenous ecosystem: raising the bar for standards and technology, contributing to the experience of…

Tagged with